Coronary microvascular dysfunction in primary cardiomyopathies
Coronary microvascular dysfunction in primary cardiomyopathies
复制标题
DOI:
10.1136/heartjnl-2013-304291
复制
发表时间:
2014-05-15
期刊:
影响因子:
5.7
通讯作者:
Camici, P. G.
中科院分区:
文献类型:
--
作者:
Spoladore, R.;Fisicaro, A.;Camici, P. G.
Myocardial ischaemia is usually caused by abnormalities of the epicardial coronary arteries. In the past 30 years, however, several studies have shown that abnormalities in the coronary microcirculation may also cause or contribute to myocardial ischaemia in several conditions. In a number of patients who present with anginal attacks in the absence of any apparent cardiac or systemic disease, coronary microvascular dysfunction (CMD) has been suggested to be the unique cause of symptoms. w1 Myocardial blood flow (MBF) abnormalities and the consequent myocardial alterations related to CMD may differ substantially from those caused by flow limiting stenoses in epicardial coronary arteries. In the latter case, the impairment of MBF is generally regional and distributed within the territories subtended by the stenosed artery, resulting in detectable segmental impairment of contractile function. In contrast, in the case of CMD, the abnormality may not necessarily involve the territory subtended by a major coronary branch, but it may affect the whole left ventricle diffusely or be distributed in a scattered manner. 1 w1 CMD may be sustained by several pathogenetic mechanisms including structural, functional, and extravascular alterations that can contribute to the condition in different ways. On the basis of the clinical settings in which it occurs, CMD can be classified into four types:(1) dysfunction occurring in the absence of coronary artery disease (CAD) and myocardial diseases;(2) dysfunction occurring in the absence of CAD, but in the presence of myocardial diseases;(3) dysfunction occurring concomitantly with CAD;(4) iatrogenic dysfunction. 1 CMD in the presence of myocardial diseases is sustained in most instances by adverse remodelling of intramural coronary arterioles, and can be identified by invasive or non-invasive assessment of coronary flow reserve (CFR). CFR—the ratio of MBF during near maximal coronary vasodilatation to basal MBF—is an integrated measure of flow through both the large epicardial coronary arteries and the microcirculation, and has been proposed as an indirect parameter to evaluate the function of the coronary circulation. An abnormal CFR can be due to narrowing of the epicardial coronary arteries or, in the absence of angiographically demonstrable atherosclerotic disease, may reflect dysfunction of the coronary microcirculation. 1 w2 More recently it has been suggested that maximum MBF (ie, MBF measured during near maximal coronary vasodilatation, eg, following intravenous adenosine) might be superior to CFR for the assessment of the coronary microcirculation. This could be explained by the fact that CFR is a ratio (ie, maximum MBF/baseline MBF) and factors that influence either the numerator or the denominator may affect its calculation. Therefore, a low CFR does not necessarily reflect a reduction of maximum flow, but it can be caused by an abnormally elevated resting flow in the face of a normal hyperaemic flow. w3CMD is found both in primary and secondary cardiomyopathies with very important prognostic implications. Cardiomyopathies are an important and heterogeneous group of diseases whose classification has proved to be exceedingly complex; indeed, through the years, various systematic classifications have been presented. The definition proposed by the last expert consensus panel of the American Heart Association is:“a heterogeneous group of diseases of the myocardium associated with mechanical and/or electrical dysfunction that usually (but not invariably) exhibit inappropriate ventricular hypertrophy or dilatation and are due to a variety of causes that frequently are genetic …